Melanoma Research Advances – 2019 in Review

Jan 28 2020

During 2019, melanoma research continued its rapid pace of advancement, with FDA approval of a new adjuvant therapy treatment option, several first-in-human…

ACS 2020 Reports Largest One-Year Drop in Cancer Mortality

Jan 08 2020

January 8, 2020:  The death rate from cancer in the US declined by 29% from 1991 to 2017, including a 2.2% drop…

Why We Run: Tim and Susan (NYC2017)

May 29 2019

In October 2015 I ran the Chicago Marathon with my wife, my sisters and my brother-in-law. I had run a few marathons…

NCI-led research team develops predictor for immunotherapy response in melanoma

Aug 28 2018

NCI Press Release:  Posted: August 20, 2018 In a new study, researchers developed a gene expression predictor that can indicate whether melanoma…

Combo Therapy Improves Outcomes in Melanoma Brain Metastasis

Oct 03 2016

Melanoma News Today: Therapies that target elements of the immune system or certain pathways active in cancer cells, in combination with radiation…

The Most Promising Cancer Therapy in Decades Is About to Get Better

Mar 11 2016

Tumors contain the seeds of their own destruction. We just need to work out how to activate them. The rise of immunotherapy…

Microneedle Patch Delivers Localized Cancer Immunotherapy to Melanoma

Mar 29 2016

NC STATE UNIVERSITY NEWS:   Biomedical engineering researchers at North Carolina State University and the University of North Carolina at Chapel Hill have…

Why We Run: Stan Sher’s Journey

Feb 23 2016

Stanley Sher of Washington, D.C. was diagnosed with an aggressive form of melanoma in 2013. After several failed treatments and surgeries, he…

FDA Approves Immunotherapy to help Prevent Relapse of Melanoma

Nov 02 2015

Patients with operable stage III melanoma can now receive the immunotherapy drug ipilimumab (Yervoy®) as adjuvant therapy to help prevent recurrence of…